Terlipressin given by continuous intravenous infusion or by intravenous boluses: Is there already an answer?

Hepatology

Gastroenterology and Hepatology Unit, Irmandade Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.

Published: December 2016

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28647DOI Listing

Publication Analysis

Top Keywords

terlipressin continuous
4
continuous intravenous
4
intravenous infusion
4
infusion intravenous
4
intravenous boluses
4
boluses answer?
4
intravenous
2
terlipressin
1
infusion
1
boluses
1

Similar Publications

This study reports the diagnosis and treatment of a 26-year-old pregnant woman with severe malnutrition combined with acute pyelonephritis causing sepsis, refractory septic shock and multiple organ failure. A female patient, 26 years old, was admitted to hospital mainly due to "menelipsis for more than 19 weeks, nausea and vomiting for 20 days, fever with fatigue for 3 days". At the end of 19 weeks of intrauterine pregnancy, the patient presented with fever accompanied by urinary tract irritation.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatorenal syndrome-acute kidney injury (HRS-AKI) is a serious complication of chronic liver disease that leads to high rates of illness and death, and terlipressin, a vasopressin analog, shows promise in treating it by effectively managing blood pressure and reducing side effects during continuous infusion.
  • This study evaluated the safety and effectiveness of administering terlipressin at a continuous rate of 4 mg/day in patients with HRS-AKI, involving 136 participants who were monitored for their response to treatment and side effects.
  • Results indicated that 69.1% of patients experienced a reduction in serum creatinine levels, with an average treatment duration of 7.6 days, although 21.
View Article and Find Full Text PDF

Long-Term Continuous Terlipressin Infusion Improves Cardiac Reserve in Patients With Decompensated Cirrhosis.

Clin Gastroenterol Hepatol

August 2024

Department of Medicine, University of Melbourne, Victoria, Australia; Victorian Liver Transplant Unit, Austin Health, Heidelberg, Australia; Australian Centre for Transplantation Excellence and Research, Melbourne, Australia; Australian Cardiovascular Collaborative in Liver Transplant Medicine, Melbourne, Australia. Electronic address:

Article Synopsis
  • Long-term use of terlipressin, a treatment for hepatorenal syndrome, may improve subclinical cardiac dysfunction in patients with decompensated cirrhosis, as suggested by a study of 22 patients.
  • After 12 weeks of terlipressin infusion, patients showed a significant increase in cardiac output in response to stress, indicating improved cardiac reserve.
  • The study found that while resting cardiac output decreased, the number of patients with impaired cardiac reserve dropped significantly, highlighting terlipressin's potential benefits in managing cardiac health in liver disease.
View Article and Find Full Text PDF

Objective: The present study investigated the impact of continuous infusion therapy with low-dose terlipressin (TP) combined with norepinephrine on hemodynamics, inflammatory markers, and prognosis in patients with severe septic shock.

Materials And Methods: Seventy-four patients with severe septic shock were randomly assigned to either a control group (n = 37) or an observation group (n = 37). Patients in the control group received norepinephrine alone, while those in the observation group received a continuous infusion of low-dose TP in addition to norepinephrine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!